Prnewswire·2025-11-20 13:00Core Insights - PTC Therapeutics, Inc. will host an R&D Day on December 2, 2025, in New York City to discuss its pipeline and provide updates on its research and development efforts [1][2]. Company Overview - PTC Therapeutics is a global biopharmaceutical company focused on discovering, developing, and commercializing clinically differentiated medicines for individuals with rare disorders [3]. - The company aims to advance a diverse pipeline of transformative medicines to meet unmet medical needs, leveraging its scientific expertise and global commercial infrastructure [3]. Event Details - The R&D Day will feature presentations from CEO Matthew B. Klein, M.D., and leaders from the PTC research and development team, focusing on proprietary small molecule splicing and inflammation platforms, including new targets and programs [2]. - The event will be webcasted, and a replay will be available for approximately 30 days post-event [2].